Leishmaniasis drug discovery: recent progress and challenges in assay development

B Zulfiqar, TB Shelper, VM Avery - Drug discovery today, 2017 - Elsevier
Highlights•Leishmaniasis remains a neglected tropical disease, with a high unmet medical
need.•Therapeutic efficacy varies depending on the species of Leishmania parasite.•Leads …

Serodiagnosis of leishmaniasis

K Kar - Critical reviews in microbiology, 1995 - Taylor & Francis
Leishmaniasis is a spectrum of diseases ranging in severity from cutaneous (CL), post-kala-
azar dermal (PKDL), and diffuse cutaneous (DCL) to mucocutaneous (MCL) and visceral …

[HTML][HTML] Co‐amplification of the γ‐glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite‐resistant Leishmania tarentolae

K Grondin, A Haimeur, R Mukhopadhyay… - The EMBO …, 1997 - embopress.org
Resistance to the oxyanion arsenite in the parasite Leishmania is multifactorial. We have
described previously the frequent amplification of the ABC transporter gene pgpA, the …

Oral delivery of ursolic acid-loaded nanostructured lipid carrier coated with chitosan oligosaccharides: Development, characterization, in vitro and in vivo assessment …

S Das, S Ghosh, AK De, T Bera - International journal of biological …, 2017 - Elsevier
Visceral leishmaniasis (VL) is a life-threatening disease caused by Leishmania donovani
due to uncontrolled parasitisation of liver, spleen, and bone marrow. Ursolic acid (UA), a …

Development and evaluation of a cedrol-loaded nanostructured lipid carrier system for in vitro and in vivo susceptibilities of wild and drug resistant Leishmania …

N Kar, S Chakraborty, AK De, S Ghosh… - European Journal of …, 2017 - Elsevier
Leishmaniasis is an epidemic in various countries, and the parasite Leishmania donovani is
developing resistance against available drugs. In the present study the antileishmanial …

[PDF][PDF] Leishmania spp: completely defined medium without serum and macromolecules (CDM/LP) for the continuous in vitro cultivation of infective promastigote forms.

T Merlen, D Sereno, N Brajon, F Rostand… - The American journal of …, 1999 - Citeseer
The elimination of serum or of serum-derived macromolecules that supplant the fetal calf
serum requirement from Leishmania culture media could decrease costs and improve the …

Oleanolic acid loaded poly lactic co-glycolic acid-vitamin E TPGS nanoparticles for the treatment of Leishmania donovani infected visceral leishmaniasis

S Ghosh, N Kar, T Bera - International journal of biological macromolecules, 2016 - Elsevier
Oleanolic acid (OA) has low aqueous solubility and low permeability, which results poor
bioavailability. To surmount the inadequacy, our aim was to fabricate oleanolic acid loaded …

In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages to Andrographolide Nanoparticle: Role of Vitamin E Derivative TPGS for …

S Mondal, P Roy, S Das, A Halder, A Mukherjee… - PLoS …, 2013 - journals.plos.org
Visceral leishmaniasis (VL) is a chronic protozoan infection in humans associated with
significant global morbidity and mortality. There is an urgent need to develop drugs and …

The Leishmania donovani LD1 locus gene ORFG encodes a biopterin transporter (BT1)

C Lemley, S Yan, VS Dole, R Madhubala… - Molecular and …, 1999 - Elsevier
We have previously described two genes, ORFF and ORFG, from the LD1 locus near one
telomere of chromosome 35, which are frequently amplified in Leishmania isolates. In …

Amphotericin B-loaded mannose modified poly (d, l-lactide-co-glycolide) polymeric nanoparticles for the treatment of visceral leishmaniasis: in vitro and in vivo …

S Ghosh, S Das, AK De, N Kar, T Bera - RSC advances, 2017 - pubs.rsc.org
It is evident from many previous research works that the mannose receptors on the surface
of macrophages play an important role in the process of phagocytosis and they are over …